Related Experiment Videos
M 154,129, a putative delta antagonist, reverses endotoxic shock without altering morphine analgesia
Abstract:
Studies were conducted with the putative delta opiate receptor antagonist M 154,129 to evaluate its potential for reversing circulatory shock without altering nociceptive processes. M 154,129 (30 mg/kg iv) did not alter tail flick or hot plate latencies by itself, nor did it alter the antinociceptive effects of morphine (4 mg/kg iv). Following endotoxic shock hypotension in conscious rats, M 154,129 (30 or 60 mg/kg iv) produced a rapid return of arterial pressure to pretreatment levels. These data indicate that circulatory shock may be mediated at delta opioid receptors. Moreover, delta antagonists may have therapeutic benefit in reversing shock without intensification of pain.
Insights
The delta opiate receptor antagonist M 154,129 reversed circulatory shock in rats without affecting pain perception. This suggests delta opioid receptors may mediate shock, offering therapeutic potential for shock treatment.
Area of Science:
- Pharmacology
- Neuroscience
- Critical Care Medicine
Background:
- Circulatory shock is a life-threatening condition characterized by inadequate tissue perfusion.
- The role of endogenous opioid systems, particularly delta opiate receptors, in the pathophysiology of shock is not fully understood.
- Developing effective treatments for shock that do not exacerbate pain is a significant clinical challenge.
Purpose of the Study:
- To investigate the efficacy of the delta opiate receptor antagonist M 154,129 in reversing endotoxic shock.
- To determine if M 154,129 alters nociceptive processes (pain perception) at doses effective for shock reversal.
- To explore the potential therapeutic benefit of delta opioid receptor antagonism in managing circulatory shock.
Main Methods:
- Administration of M 154,129 (30 mg/kg intravenously) in conscious rats to assess its effects on tail flick and hot plate latencies (measures of pain).
- Evaluation of M 154,129's impact on the antinociceptive effects of morphine.
- Induction of endotoxic shock hypotension in rats, followed by administration of M 154,129 (30 or 60 mg/kg intravenously) to monitor arterial pressure.
- Monitoring of arterial pressure to assess the reversal of hypotension.
Main Results:
- M 154,129 alone did not alter pain response latencies (tail flick, hot plate).
- M 154,129 did not interfere with the pain-relieving effects of morphine.
- In rats with endotoxic shock-induced hypotension, M 154,129 administration led to a rapid restoration of arterial pressure to baseline levels.
- The effective doses for shock reversal did not potentiate pain.
Conclusions:
- Circulatory shock may involve mechanisms mediated by delta opioid receptors.
- Delta opiate receptor antagonists, such as M 154,129, show promise in reversing circulatory shock.
- These findings suggest a potential therapeutic strategy for shock that avoids increasing pain sensitivity.